NCT05881733View on ClinicalTrials.gov

Effect of a Bigger Cryoballoon on the Total Antral Lesion Size: Evaluation of POLARx FIT

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

July 31, 2025

Conditions
Atrial Fibrillation
Interventions
DEVICE

POLARx FIT cryoballoon

Patients will undergo cryoablation with the 31 mm balloon size of the POLARx FIT cryoballoon.

Trial Locations (1)

3015 GD

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Erasmus Medical Center

OTHER